Laparoscopic Adjustable Gastric Banding for Morbidly Obese Adolescents Affects Android Fat Loss, Resolution of Comorbidities, and Improved Metabolic Status

被引:57
作者
Nadler, Evan P. [1 ,2 ]
Reddy, Shivani [1 ,2 ]
Isenalumhe, Anthony [1 ,2 ]
Youn, Heekoung A. [2 ]
Peck, Valerie [2 ,3 ]
Ren, Christine J. [2 ]
Fielding, George A. [2 ]
机构
[1] NYU, Sch Med, Div Pediat Surg, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Surg, New York, NY 10016 USA
[3] NYU, Sch Med, Dept Med, New York, NY 10016 USA
关键词
SURGICAL WEIGHT-LOSS; INSULIN-RESISTANCE; DIABETES-MELLITUS; BARIATRIC SURGERY; TYPE-2; PREVALENCE; BYPASS; POPULATION; DEFINITION; EXPERIENCE;
D O I
10.1016/j.jamcollsurg.2009.07.022
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: The distribution of weight loss and its impact on metabolic health has not been documented for laparoscopic adjustable gastric banding (LAGB) in the adolescent population. We hypothesized that LAGB in obese adolescents would result in loss of android fat mass, resolution of comorbidities, and improvement in metabolic status. STUDY DESIGN: Adolescents ages 14 to 17 who met criteria for bariatric surgery were enrolled in our FDA-approved LAGB trial. Demographic data, body mass index, body composition and bone density, laboratory evaluations, and comorbid conditions were assessed pre- and postoperatively. RESULTS: Forty-five patients had complete 1-year followup and 41 patients had complete 2-year followup. Mean preoperative weight was 299 +/- 57 lb and body mass index was 48 +/- 6.4 kg/m(2). The percent excess weight losses at 6 months, 1 year, and 2 years were 31 +/- 16, 46 +/- 21, and 47 +/- 22, respectively. At 1-year followup, patients after LAGB had a significant decrease in their total and android fat mass. In addition, 47 of 85 identified comorbidities (55%) were completely resolved and 25 (29%) were improved in comparison with baseline. Improvements in alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, hemoglobin Alc, fasting insulin, triglycerides, and high density lipoprotein, were also seen. CONCLUSIONS: The percent excess weight loss after LAGB in morbidly obese adolescents is approximately 45% at 1- and 2-year followup, with the majority of weight loss consisting of android fat mass. Resolution or improvement of comorbidities is seen, and improved metabolic status, as demonstrated by liver function tests, lipid levels, and measures of glucose homeostasis, may be expected. These data support LAGB as an appropriate surgical option for morbidly obese adolescents. (J Am Coll Surg 2009;209:638-644. (C) 2009 by the American College of Surgeons)
引用
收藏
页码:638 / 644
页数:7
相关论文
共 28 条
[1]  
[Anonymous], 1996, Nutrition, V12, P397
[2]   Harmonizing the definition of the metabolic syndrome: Comparison of the Criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations [J].
Assmann, Gerd ;
Guerra, Rudy ;
Fox, Garrett ;
Cullen, Paul ;
Schulte, Helmut ;
Willett, DuWayne ;
Grundy, Scott M. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (04) :541-548
[3]   Improvement in comorbid illness after placement of the Swedish Adjustable Gastric Band [J].
Brancatisano, Anthony ;
Wahlroos, Sara ;
Brancatisano, Roy .
SURGERY FOR OBESITY AND RELATED DISEASES, 2008, 4 (03) :S39-S46
[4]   Body composition and metabolic changes following bariatric surgery: Effects on fat mass, lean mass and basal metabolic rate: Six months to one-year follow-up [J].
Carey, Daniel Gene ;
Pliego, German J. ;
Raymond, Robert L. .
OBESITY SURGERY, 2006, 16 (12) :1602-1608
[5]   Influence of obesity and surgical weight loss on thyroid hormone levels [J].
Chikunguwo, Silas ;
Brethauer, Stacy ;
Nirujogi, Vijaya ;
Pitt, Tracy ;
Udomsawaengsup, Suthep ;
Chand, Bipan ;
Schauer, Philip .
SURGERY FOR OBESITY AND RELATED DISEASES, 2007, 3 (06) :631-635
[6]  
de Moraes CMM, 2005, OBES SURG, V15, P1287
[7]   Abdominal obesity and metabolic syndrome [J].
Despres, Jean-Pierre ;
Lemieux, Isabelle .
NATURE, 2006, 444 (7121) :881-887
[8]   Obesity and the white blood cell count: Changes with sustained weight loss [J].
Dixon, JB ;
O'Brien, PE .
OBESITY SURGERY, 2006, 16 (03) :251-257
[9]   Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions [J].
Duseja, Ajay ;
Das, Ashim ;
Dhiman, Radha Krishan ;
Chawla, Yogesh Kumar ;
Thumburu, Kiran K. ;
Bhadada, Sanjay ;
Bhansali, Anil .
ANNALS OF HEPATOLOGY, 2007, 6 (04) :222-226
[10]  
Feasel J, 2006, J AM COLL SURGEONS, V203, pS54, DOI 10.1016/j.jamcollsurg.2006.03.019